XLV Holdings Information

XLV is an equity ETF with a total of 63 individual holdings. The top holdings are Eli Lilly and Company stock at 14.19%, Johnson & Johnson at 10.33%, AbbVie at 7.08%, Merck & Co. at 5.29%, and UnitedHealth Group at 4.57%.

Total Holdings

Top 10 Percentage

58.28%

Asset Class

Equity

ETF Category

Health

Assets

41.94B

PE Ratio

22.91

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	14.19%	5,819,154
2	JNJ	Johnson & Johnson	10.33%	17,654,814
3	ABBV	AbbVie Inc.	7.08%	12,951,060
4	MRK	Merck & Co., Inc.	5.29%	18,187,741
5	UNH	UnitedHealth Group Incorporated	4.57%	6,637,789
6	AMGN	Amgen Inc.	3.58%	3,945,879
7	ABT	Abbott Laboratories	3.45%	12,742,082
8	TMO	Thermo Fisher Scientific Inc.	3.38%	2,753,126
9	GILD	Gilead Sciences, Inc.	3.32%	9,091,415
10	ISRG	Intuitive Surgical, Inc.	3.11%	2,597,662
11	PFE	Pfizer Inc.	2.72%	41,663,788
12	DHR	Danaher Corporation	2.29%	4,606,598
13	SYK	Stryker Corporation	2.27%	2,522,085
14	MDT	Medtronic plc	2.21%	9,398,780
15	BMY	Bristol-Myers Squibb Company	2.13%	14,917,551
16	VRTX	Vertex Pharmaceuticals Incorporated	2.09%	1,859,219
17	MCK	McKesson Corporation	2.05%	904,451
18	BSX	Boston Scientific Corporation	1.98%	10,863,065
19	CVS	CVS Health Corporation	1.73%	9,302,163
20	HCA	HCA Healthcare, Inc.	1.50%	1,170,522
21	REGN	Regeneron Pharmaceuticals, Inc.	1.40%	738,492
22	CI	The Cigna Group	1.36%	1,957,433
23	ELV	Elevance Health, Inc.	1.35%	1,628,523
24	COR	Cencora, Inc.	1.22%	1,420,696
25	ZTS	Zoetis Inc.	1.00%	3,229,284

Showing 25 of 63 holdings

Subscribe to see the full list

Activate Now

As of Feb 18, 2026